Daria Mochly-Rosen
From Wikipedia, the free encyclopedia
American biologist and researcher
Daria Mochly-Rosen is a Professor of Chemical and Systems Biology at the Stanford University School of Medicine, where she also holds the George D. Smith Chair for Translational Medicine.[1] She is in addition the founder of Mitoconix Bio, a startup company whose goal is to produce drugs that treat Huntington's disease and other neurodegenerative illnesses.[2] [3] [4]
References
[edit ]- ^ "Daria Mochly-Rosen". Stanford University . Retrieved 2018年08月12日.
- ^ "Neurological therapy co Mitoconix Bio raises 20ドルm". Globes. Retrieved 2017年06月27日.
- ^ "California Life Sciences Association (CLSA) Adds Leaders from City of Hope, Stanford to Board of Directors" . Retrieved 2017年02月13日.[permanent dead link ]
- ^ Danney, Micah (2017年07月05日). "Israeli startup takes aim at Huntington's disease". The Times of Israel . Retrieved 2018年08月12日.
External links
[edit ]- Daria Mochly-Rosen publications indexed by Google Scholar
